PEDIASTENT LLC - IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.
Key Details
Description
IGF::OT::IGF THE DEVELOPMENT LEADING TO THE COMMERCIALIZATION OF A BIORESORBABLE STENTS (BRS) FOR THE TREATMENT OF COARCTATION OF THE AORTA (COA) IN NEONATES.
Context & Analysis
On Feb 9, 2026, Department of Health and Human Services obligated $3,399,279 to PEDIASTENT LLC for igf::ot::igf the development leading to the commercialization of a bioresorbable stents (brs) for the treatment of coarctation of the aorta (coa) in neonates.. The award is classified under NAICS 541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 4 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in CLEVELAND, OH. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541712 — related awards are listed below.
Contractor Information
Similar Awards
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NATIONAL TOXICOLOGY PROGRAM
RESEARCH TRIANGLE INSTITUTE
$54.3M
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NATIONAL TOXICOLOGY PROGRAM
RESEARCH TRIANGLE INSTITUTE
$54.3M
IGF::OT::IGF CHEMISTRY SERVICES FOR THE NTP
MRIGLOBAL
$50.9M
IGF::CL::IGF WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER
FRED HUTCHINSON CANCER RESEARCH CENTER
$49.7M
IGF::OT::IGFCHEMISTRY SERVICES FOR THE NTP
BATTELLE MEMORIAL INSTITUTE
$43.2M
Stay Updated
Get notified about new opportunities matching your interests.